Avacta Group (AVCT) Stock Chart & Stock Price History → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free AVCT Stock Alerts GBX 48.50 +0.50 (+1.04%) (As of 04/19/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Avacta Group Stock Price Performance5 Day Performance-6.28%1 Month Performance-6.73%3 Month Performance-53.37%6 Month Performance-62.97%Year-To-Date Performance-58.37%1 Year Performance-62.40% Receive AVCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! AVCT Stock Chart for Friday, April, 19, 2024 AVCT Chart by TradingView Avacta Group Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024GBX 49.75GBX 48.11-3.30%GBX 49.07GBX 47.503.07 million shs£168.63 million04/17/2024GBX 50.75GBX 49.75-1.97%GBX 50.77GBX 49.501.77 million shs£174.38 million04/16/2024GBX 51.50GBX 50.75-1.46%GBX 51.70GBX 50.501.48 million shs£177.88 million04/15/2024GBX 51.75GBX 51.50-0.48%GBX 52.10GBX 50.501.81 million shs£180.51 million04/12/2024GBX 52.50GBX 51.75-1.43%GBX 53GBX 51.281.93 million shs£181.39 million04/11/2024GBX 54GBX 52.50-2.78%GBX 54.50GBX 521.79 million shs£184.02 million Get the Latest News and Ratings for AVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024GBX 53.61GBX 54+0.73%GBX 57.90GBX 534.87 million shs£189.28 million04/09/2024GBX 53.50GBX 53.61+0.21%GBX 54GBX 512.92 million shs£187.91 million04/08/2024GBX 52.50GBX 53.50+1.90%GBX 56GBX 52.239.58 million shs£187.52 million04/05/2024GBX 49.57GBX 52.50+5.91%GBX 52.85GBX 49.754.21 million shs£184.02 million04/04/2024GBX 49.50GBX 49.57+0.14%GBX 50.90GBX 49.502.52 million shs£173.75 million04/03/2024GBX 50.25GBX 49.50-1.49%GBX 50.25GBX 48.421.97 million shs£173.50 million04/02/2024GBX 49.75GBX 50.25+1.01%GBX 51GBX 49.502.68 million shs£176.13 million04/01/2024GBX 49.75GBX 49.75GBX 50GBX 47.333.37 million shs£174.38 million03/29/2024GBX 49.75GBX 49.75GBX 50GBX 47.333.37 million shs£174.38 million03/28/2024GBX 49GBX 49.75+1.53%GBX 50GBX 47.333.37 million shs£157.08 million03/27/2024GBX 50.90GBX 49-3.73%GBX 51.25GBX 48.574.17 million shs£154.71 million03/26/2024GBX 50.44GBX 50.90+0.90%GBX 52GBX 50.552.17 million shs£160.71 million03/25/2024N/AGBX 50.44GBX 51.50GBX 50.182.49 million shs£159.27 million03/22/2024GBX 52GBX 51.62-0.73%GBX 53.25GBX 502.94 million shs£162.99 million03/21/2024GBX 52.70GBX 52-1.33%GBX 54.38GBX 522.97 million shs£164.19 million03/20/2024GBX 52GBX 52.70+1.35%GBX 54.50GBX 52.472.14 million shs£166.40 million03/19/2024GBX 50.01GBX 52+3.98%GBX 53GBX 50.503.33 million shs£164.19 million03/18/2024GBX 52.25GBX 50.01-4.29%GBX 52.75GBX 505.38 million shs£157.90 million03/15/2024GBX 52.31GBX 52.01-0.57%GBX 53.50GBX 51.631.60 million shs£164.22 million03/14/2024GBX 53.32GBX 52.31-1.90%GBX 54GBX 521.61 million shs£165.16 million03/13/2024GBX 55.68GBX 53.32-4.23%GBX 55.40GBX 53.062.45 million shs£168.36 million03/12/2024GBX 56.80GBX 55.68-1.97%GBX 58GBX 54.202.16 million shs£175.80 million03/11/2024GBX 58GBX 56.80-2.07%GBX 59.50GBX 56.503.25 million shs£179.34 million03/08/2024GBX 55GBX 58+5.45%GBX 58.50GBX 55.304.51 million shs£183.13 million03/07/2024GBX 52.25GBX 55+5.26%GBX 56GBX 523.97 million shs£173.66 million03/06/2024GBX 52.75GBX 52.25-0.95%GBX 52.79GBX 521.79 million shs£150.60 million03/05/2024GBX 53.25GBX 52.75-0.94%GBX 55GBX 51.252.85 million shs£152.04 million03/04/2024GBX 54.50GBX 53.25-2.29%GBX 54GBX 52.784.22 million shs£153.48 million03/01/2024GBX 54.50GBX 54.50GBX 55.85GBX 52.577.76 million shs£157.08 million02/29/2024GBX 74.70GBX 54.50-27.04%GBX 57GBX 5024.23 million shs£157.08 million02/28/2024GBX 75.80GBX 74.70-1.45%GBX 78.75GBX 674.21 million shs£215.30 million02/27/2024GBX 81.90GBX 75.80-7.45%GBX 83GBX 73.652.50 million shs£218.47 million02/26/2024GBX 86GBX 81.90-4.77%GBX 88.75GBX 772.88 million shs£236.05 million02/23/2024GBX 77GBX 86+11.69%GBX 90GBX 72.107.07 million shs£247.93 millionTiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/22/2024GBX 87.98GBX 77-12.48%GBX 88.60GBX 76.552.91 million shs£221.98 million02/21/2024GBX 91.50GBX 87.98-3.85%GBX 90.80GBX 872.12 million shs£253.64 million02/20/2024GBX 93.68GBX 91.50-2.33%GBX 95GBX 91.11967,163 shs£263.79 million02/19/2024GBX 94GBX 93.68-0.34%GBX 94GBX 89.542.20 million shs£270.07 million02/16/2024GBX 95.87GBX 95-0.91%GBX 97GBX 931.17 million shs£273.88 million02/15/2024GBX 100.50GBX 95.87-4.61%GBX 101.01GBX 95.06935,400 shs£276.38 million02/14/2024GBX 97GBX 100.50+3.61%GBX 101.80GBX 95.30809,846 shs£289.73 million02/13/2024GBX 98GBX 97-1.02%GBX 99.10GBX 941.15 million shs£279.64 million02/12/2024GBX 100GBX 98-2.00%GBX 100.25GBX 971.20 million shs£282.52 million02/09/2024GBX 101GBX 100-0.99%GBX 102.75GBX 991.02 million shs£288.29 million02/08/2024GBX 102GBX 101-0.98%GBX 103.75GBX 101719,511 shs£291.17 million02/07/2024GBX 102.50GBX 102-0.49%GBX 103GBX 1011.05 million shs£294.06 million02/06/2024GBX 105.59GBX 102.50-2.93%GBX 105.49GBX 1001.04 million shs£295.50 million02/05/2024GBX 108.50GBX 105.59-2.68%GBX 110GBX 104.101.00 million shs£304.41 million02/02/2024GBX 105GBX 108.50+3.33%GBX 110GBX 104.501.34 million shs£307.72 million02/01/2024GBX 103.74GBX 105+1.22%GBX 105.50GBX 102.40846,200 shs£297.79 million01/31/2024GBX 104.80GBX 103.74-1.02%GBX 106GBX 102.301.47 million shs£294.20 million01/30/2024GBX 100GBX 104.80+4.80%GBX 107.97GBX 99988,383 shs£297.22 million01/29/2024GBX 100.50GBX 100-0.50%GBX 101GBX 98.501.13 million shs£283.61 million01/26/2024GBX 101.50GBX 100.50-0.99%GBX 102.63GBX 100954,831 shs£285.03 million01/25/2024GBX 102.50GBX 101.50-0.98%GBX 103.85GBX 1001.03 million shs£287.86 million01/24/2024GBX 104GBX 102.50-1.44%GBX 106.70GBX 102962,877 shs£290.70 million01/23/2024GBX 101GBX 104+2.97%GBX 105.25GBX 100.831.13 million shs£294.95 million01/22/2024GBX 104GBX 101-2.88%GBX 105GBX 98.502.65 million shs£286.45 million01/19/2024GBX 104.50GBX 104-0.48%GBX 105.98GBX 103.02624,964 shs£294.95 million01/18/2024GBX 105GBX 104.50-0.48%GBX 105GBX 103.10934,140 shs£296.37 million Related Companies: hVIVO Stock Price Chart Arix Bioscience Stock Price Chart Oxford Biomedica Stock Price Chart Bioventix Stock Price Chart 4basebio Stock Price Chart Futura Medical Stock Price Chart Faron Pharmaceuticals Oy Stock Price Chart Scancell Stock Price Chart e-therapeutics Stock Price Chart Poolbeg Pharma Stock Price Chart Receive AVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AVCT) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.